Hofseth BioCare ASA (HOFBF)
HOFBF Stock Price Chart
Explore Hofseth BioCare ASA interactive price chart. Choose custom timeframes to analyze HOFBF price movements and trends.
HOFBF Company Profile
Discover essential business fundamentals and corporate details for Hofseth BioCare ASA (HOFBF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
22 Aug 2018
Employees
72.00
Website
https://www.hofsethbiocare.noCEO
Jon Olav Odegard
Description
Hofseth BioCare ASA engages in providing value added biomarine ingredients for human and animal applications in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; CalGo, a marine calcium powder produced to support cartilage function and joint health; CollaGo, a collagen peptide powder to enhance the beauty of hair, skin, and nails; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force. It has a research agreement with Stanford University School of Medicine for pre-clinical and clinical research on necrotizing enterocolitis and irritable bowel syndrome. The company was founded in 2000 and is headquartered in Ålesund, Norway.
HOFBF Financial Timeline
Browse a chronological timeline of Hofseth BioCare ASA corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 9 May 2025
EPS came in at -$0.01 , while revenue for the quarter reached $5.66M .
Earnings released on 31 Dec 2024
EPS came in at -$0.01 , while revenue for the quarter reached $5.71M .
Earnings released on 30 Sept 2024
EPS came in at -$0.01 , while revenue for the quarter reached $6.37M .
Earnings released on 29 Jun 2024
EPS came in at -$0.00 , while revenue for the quarter reached $7.56M .
Earnings released on 10 May 2024
EPS came in at -$0.01 , while revenue for the quarter reached $4.74M .
Earnings released on 4 Jan 2024
EPS came in at -$0.01 , while revenue for the quarter reached $4.53M .
Earnings released on 30 Sept 2023
EPS came in at -$0.01 , while revenue for the quarter reached $4.61M .
Earnings released on 30 Jun 2023
EPS came in at $0.00 , while revenue for the quarter reached $4.92M .
Earnings released on 31 Mar 2023
EPS came in at -$0.01 , while revenue for the quarter reached $4.30M .
Earnings released on 31 Dec 2022
EPS came in at -$0.01 , while revenue for the quarter reached $3.47M .
Earnings released on 30 Sept 2022
EPS came in at -$0.01 , while revenue for the quarter reached $2.81M .
Earnings released on 30 Jun 2022
EPS came in at -$0.01 , while revenue for the quarter reached $2.61M .
Earnings released on 31 Mar 2022
EPS came in at -$0.01 , while revenue for the quarter reached $3.53M .
Earnings released on 31 Dec 2021
EPS came in at -$0.01 , while revenue for the quarter reached $2.96M .
Earnings released on 30 Sept 2021
EPS came in at -$0.01 , while revenue for the quarter reached $1.57M .
Earnings released on 30 Jun 2021
EPS came in at -$0.01 , while revenue for the quarter reached $3.61M .
Earnings released on 31 Mar 2021
EPS came in at -$0.01 , while revenue for the quarter reached $1.97M .
Earnings released on 31 Dec 2020
EPS came in at -$0.01 , while revenue for the quarter reached $2.69M .
Earnings released on 30 Sept 2020
EPS came in at -$0.01 , while revenue for the quarter reached $813.08K .
HOFBF Stock Performance
Access detailed HOFBF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.